Commercialization Success OBEST...

With the global economy still in recovery two years after the economic downturn, Ontario’s bioscience industry and a universe if pan- Ontario stakeholders seized the opportunity to contribute to Ontario’s economic growth and developed a comprehensive, implementable plan for a vibrant biosciences industry. Developed by OBIO, the plan is named, OBEST (Ontario Biosciences Economic Strategy Team) and articles...

Ontario’s Bioscience Industry – Transl...

The Ontario Bioscience Industry Organization (OBIO) works to advance the development and growth of a sustainable, commercially – driven, life sciences industry in Ontario. OBIO is a private sector, membership-based organization representing Ontario’s human-health bioscience industry. Key among Ontario’s bioscience strengths are a pipeline of high value, early stage intellectual property and start-up...

Leveraging the $7 Million Fund – Designated ...

During the fall of 2009, with Ontario’s bioscience industry fighting for survival due to an inability to raise capital in the midst of a world-wide economic crisis, OBIO mobilized industry CEOs to take action. With a sense of urgency derived from the need for a plan to ensure the survival of the industry, OBIO organized its first province-wide consultation process ultimately generating a set of recommendations for industry...

The Best Laid Plans – How OBIO™ is looking...

Innovation and Bioscience go hand and hand. It is a symbiotic relationship – both depend on one another. Yet, for Ontario, a province teeming with groundbreaking initiatives in the bioscience field, there is something missing. A broken link between this would-be flourishing industry and reality. True, the recession of 2008 to 2009 hit the industry hard, but the seeds of insufficiency were planted far earlier. For most...

Q3 2010 Canadian Healthcare Review...

Financings A weak financing climate for Canadian public healthcare companies continued in the third quarter. Gross proceeds of equity and convertible debt financings completed in the third quarter amounted to $65.5 million (Appendix 1), bringing the total for the first nine months of 2010 to $374.2 million.  In order to get a true assessment of the financing situation for public development stage companies, financings for...